Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNS Marinus Pharmaceuticals

未开盘 11-18 16:00:00 EST

0.3080

+0.0062

+2.05%

盘后0.3101

+0.0021+0.68%

19:54 EST

最高0.3249	最低0.3001	成交量129.07万
今开0.3068	昨收0.3018	日振幅8.22%
总市值1,697万	流通市值1,228万	总股本5,508万
成交额40.00万	换手率3.24%	流通股本3,988万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNS","market":"US","secType":"STK","nameCN":"Marinus Pharmaceuticals","latestPrice":0.308,"timestamp":1731963600000,"preClose":0.3018,"halted":0,"volume":1290665,"hourTrading":{"tag":"盘后","latestPrice":0.3101,"preClose":0.308,"latestTime":"19:54 EST","volume":7610,"amount":2350.7422,"timestamp":1731977681606},"delay":0,"floatShares":39882562,"shares":55084038,"eps":-2.466183,"marketStatus":"未开盘","marketStatusCode":0,"change":0.0062,"latestTime":"11-18 16:00:00 EST","open":0.3068,"high":0.3249,"low":0.3001,"amount":399983.0979989,"amplitude":0.082174,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.466183,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1406779200000,"adjPreClose":0.3018,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.3016,"preClose":0.3018,"latestTime":"09:27 EST","volume":625,"amount":189.0002,"timestamp":1731940038302},"postHourTrading":{"tag":"盘后","latestPrice":0.3101,"preClose":0.308,"latestTime":"19:54 EST","volume":7610,"amount":2350.7422,"timestamp":1731977681606},"volumeRatio":0.92144,"impliedVol":0.1888,"impliedVolPercentile":0.0199},"requestUrl":"/m/hq/s/MRNS","defaultTab":"news","newsList":[{"id":"2484067073","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘大幅上涨6.00%报0.320美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484067073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484067073?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:59","pubTimestamp":1731945564,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时59分，Marinus Pharmaceuticals, Inc.股票出现波动，股价快速拉升6.00%。截至发稿，该股报0.320美元/股，成交量39.3001万股，换手率0.71%，振幅6.26%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235924abccd35b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235924abccd35b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2483864048","title":"Marinus Pharmaceuticals, Inc.2024财年第三财季实现净利润-24.23百万美元，同比增加26.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483864048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483864048?lang=zh_cn&edition=full","pubTime":"2024-11-14 08:00","pubTimestamp":1731542419,"startTime":"0","endTime":"0","summary":"11月14日，Marinus Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-24.23百万美元，同比增加26.51%；其中营业收入为8.54百万美元，同比增加16.35%，每股基本收益为-0.42美元。机构评级：截至2024年11月14日，当前有6家机构对Marinus Pharmaceuticals, Inc.目标价做出预测，其中目标均价为1.83美元，其中最低目标价为0.50美元，最高目标价为4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080020a2355865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080020a2355865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS"],"gpt_icon":0},{"id":"2483243881","title":"Marinus Pharmaceuticals, Inc.盘中异动 大幅下跌8.38%报0.316美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483243881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483243881?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:32","pubTimestamp":1731508336,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时32分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅跳水8.38%。截至发稿，该股报0.316美元/股，成交量6.9605万股，换手率0.13%，振幅2.15%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Mersana Therapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为329.62%、174.16%、84.72%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Mersana Therapeutics, Inc.、Lexeo Therapeutics, Inc.，振幅分别为14.89%、10.27%、9.75%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223216a2345422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223216a2345422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2481101713","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101713?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:43","pubTimestamp":1731076995,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时43分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.60%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Matinas Biopharma Holdings, Inc.、Fortrea Holdings Inc.、Inhibikase Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为449.83%、30.24%、18.84%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Matinas Biopharma Holdings, Inc.，振幅分别为86.00%、31.72%、23.50%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224315971a5612&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224315971a5612&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2481493709","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481493709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481493709?lang=zh_cn&edition=full","pubTime":"2024-11-07 03:20","pubTimestamp":1730920835,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日03时20分，Marinus Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.62%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为3373.67%、505.53%、152.44%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Cardio Diagnostics Holdings Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为128.03%、82.72%、59.87%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107032035aba737de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107032035aba737de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2480058584","title":"Marinus Pharmaceuticals, Inc.盘中异动 急速下挫5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480058584?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:56","pubTimestamp":1730732185,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时56分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.28%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Neurogene Inc.、Disc Medicine, Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为256.46%、210.05%、56.09%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.，振幅分别为31.90%、29.83%、25.56%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务，即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225625ab9eca44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225625ab9eca44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2480884495","title":"Marinus Pharmaceuticals Inc   预计每股亏损41美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480884495","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480884495?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:14","pubTimestamp":1730470461,"startTime":"0","endTime":"0","summary":"   * Marinus Pharmaceuticals Inc    预计将在11月5日公布截至0001年1月1日的业绩报告(预计)，季度收入将有所增长。* 根据LSEG的数据，10位分析师的平均预期显示，这家总部位于宾夕法尼亚州Radnor的公司的营收预计将从去年同期的734万美元增长28.3%，达到941.8万美元。* LSEG分析师对Marinus Pharmaceuticals Inc的平均预期是每股亏损41美分。* 华尔街对 Marinus Pharmaceuticals Inc 的 12 个月目标价中位数为 2.00 美元，高于上一次收盘价 0.30 美元。11月1日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Marinus Pharmaceuticals Inc   预计每股亏损41美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNS"],"gpt_icon":0},{"id":"2480066409","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.11%报0.303美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480066409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480066409?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:56","pubTimestamp":1730404580,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日03时56分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.11%。截至发稿，该股报0.303美元/股，成交量259.281万股，换手率4.71%，振幅6.33%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.91%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101035620971a3a01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101035620971a3a01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2479283321","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479283321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479283321?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:35","pubTimestamp":1730208926,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时35分，Marinus Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.41%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为551.79%、256.22%、143.71%，振幅较大的相关个股有Glycomimetics, Inc.、Lixte Biotechnology Holdings, Inc.、Coya Therapeutics, Inc.，振幅分别为54.10%、25.95%、17.17%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213526a1f5a2d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213526a1f5a2d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2478486055","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘大幅下挫5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478486055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478486055?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:30","pubTimestamp":1730122221,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时30分，Marinus Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.46%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Revance Therapeutics, Inc.、Immunitybio, Inc.涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为534.84%、47.79%、35.84%，振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、Avid Bioservices, Inc.、Nrx Pharmaceuticals, Inc.，振幅分别为4.31%、3.90%、3.31%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务，即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821302198e3eccc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821302198e3eccc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2478789336","title":"美国研究综述-Appfolio、标普全球、优步","url":"https://stock-news.laohu8.com/highlight/detail?id=2478789336","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478789336?lang=zh_cn&edition=full","pubTime":"2024-10-25 14:47","pubTimestamp":1729838867,"startTime":"0","endTime":"0","summary":"    路透10月25日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Appfolio、标普全球和优步。要闻             * Appfolio Inc   ：Piper Sandler将目标价从300美元下调至265美元             * Marinus Pharmaceuticals Inc   ：TD Cowen将目标价从买入下调至持有             * 纽蒙特   ：丰业银行将其评级从 \"跑赢大市 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0d7308f866f3de0fe4454f56a883ee8f","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PEGA","LU0787776722.HKD","IE0004445015.USD","LU0127658192.USD","NDAQ","MOH","LU0868494617.USD","NEP","LU0788108826.HKD","BK4097","APPF","LU0300736492.USD","KDP","DLR","LU2210150020.SGD","BK4529","TYL","HON","FCNCA","BK4104","BK4551","LU0788109121.HKD","BK4535","LU2463526074.USD","AIT","UCB","HAS","SKX","SPGI","CVLG","TPR","EW","IE00BZ199S13.USD","LU0719512351.SGD","LU1861214812.USD","DECK","LYFT","UBER","UPS","DXCM","PRGS","LU1989764664.SGD","LU0310800965.SGD","LU1989763690.USD","BK4504","UNP","LU1003077747.HKD","NEM","MRNS"],"gpt_icon":1},{"id":"2478678980","title":"美国研究综述-Appfolio、标普全球、优步","url":"https://stock-news.laohu8.com/highlight/detail?id=2478678980","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478678980?lang=zh_cn&edition=full","pubTime":"2024-10-25 14:47","pubTimestamp":1729838867,"startTime":"0","endTime":"0","summary":"    路透10月25日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Appfolio、标普全球和优步。要闻             * Appfolio Inc   ：Piper Sandler将目标价从300美元下调至265美元             * Marinus Pharmaceuticals Inc   ：TD Cowen将目标价从买入下调至持有             * 纽蒙特   ：丰业银行将其评级从 \"跑赢大市 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0d7308f866f3de0fe4454f56a883ee8f","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861214812.USD","BK4104","NEM","DECK","BK4551","CVLG","LU0788109121.HKD","MOH","PRGS","TYL","SKX","DXCM","LU0300736492.USD","BK4529","DLR","LYFT","BK4082","HON","AIT","PEGA","LU0788108826.HKD","APPF","LU0310800965.SGD","UNP","UBER","BK4097","LU0719512351.SGD","LU0127658192.USD","LU2463526074.USD","SPGI","BK4535","BK4504","EW","IE0004445015.USD","LU2210150020.SGD","LU1003077747.HKD","TPR","NEP","UCB","UPS","KDP","LU1989764664.SGD","LU0787776722.HKD","NDAQ","IE00BZ199S13.USD","LU0868494617.USD","MRNS","FCNCA","LU1989763690.USD","HAS"],"gpt_icon":1},{"id":"2478654439","title":"BUZZ-停止开发罕见病药物，Marinus创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2478654439","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478654439?lang=zh_cn&edition=full","pubTime":"2024-10-25 00:07","pubTimestamp":1729786075,"startTime":"0","endTime":"0","summary":"10月24日 -  ** 疗法开发商Marinus Pharmaceuticals MRNS.O股价下跌约82.8%，创下29美分的历史新低 ** 该公司称，在一项针对罕见遗传性脑病 \"结节性硬化综合征\"（tuberous sclerosis complex(TSC）患者的晚期试验中，该公司的口服药物甘纳昔隆（ganaxolone）未能达到主要目标，因此该公司将停止 (link)。) ** MRNS 公司称，该药物并未显著降低 TSC 相关性癫痫发作的频率。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241024:nL4S3M028H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2477317632","title":"Marinus Pharmaceuticals, Inc.股价重挫69.46% 市值跌1975.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477317632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477317632?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:32","pubTimestamp":1729776751,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时32分，Marinus Pharmaceuticals, Inc.股票出现异动，股价大幅下挫69.46%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.、Chromocell Therapeutics Corporation涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为197.73%、96.52%、32.10%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Hepion Pharmaceuticals, Inc.，振幅分别为41.04%、20.04%、12.73%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421323195bd4d88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421323195bd4d88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2477633851","title":"BUZZ-停止开发罕见病药物后，Marinus公司股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2477633851","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477633851?lang=zh_cn&edition=full","pubTime":"2024-10-24 20:49","pubTimestamp":1729774166,"startTime":"0","endTime":"0","summary":"    10月24日 - ** 疗法开发商Marinus Pharmaceuticals   的股价盘前下跌~61.5%至65美分** 该公司称，在一项针对罕见遗传性脑部疾病 \"结节性硬化综合征\"（tuberous sclerosis complex(TSC）患者的后期试验中，其口服药物甘纳昔隆（ganaxolone）未能达到主要目标，因此该公司将停止 (link)。)** MRNS 公司称，该药物并未显著降低 TSC 相关性癫痫发作的频率。** 该公司称正在探索战略替代方案，并采取更多措施降低成本，包括裁员** 截至上次收盘，股价年累计下跌 84.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2477743682","title":"由于罕见病药物试验失败，Marinus Pharma 公司将寻求其他方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2477743682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477743682?lang=zh_cn&edition=full","pubTime":"2024-10-24 20:09","pubTimestamp":1729771769,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透10月24日 - 马里努斯制药公司  周四表示，由于其治疗一种罕见脑部疾病发作的药物在一项后期研究中未能达到主要目标，该公司正在探索战略替代方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2477984361","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477984361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477984361?lang=zh_cn&edition=full","pubTime":"2024-10-23 02:34","pubTimestamp":1729622046,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日02时34分，Marinus Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.22%。截至发稿，该股报1.73美元/股，成交量32.2285万股，换手率0.59%，振幅6.32%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为5573.15%、5000.82%、2148.35%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为189.27%、101.99%、99.41%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102302340698e3dd2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102302340698e3dd2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2477810865","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.14%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477810865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477810865?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:47","pubTimestamp":1729518463,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时47分，Marinus Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.14%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Gri Bio, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Biovie Inc.涨幅较大，Gri Bio, Inc.、Biovie Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为2078.86%、509.58%、276.10%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Gri Bio, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为116.08%、91.38%、59.45%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121474398e3d87d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121474398e3d87d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2476263787","title":"Marinus Pharmaceuticals, Inc.盘中异动 大幅拉升5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476263787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476263787?lang=zh_cn&edition=full","pubTime":"2024-10-18 23:29","pubTimestamp":1729265351,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日23时29分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.46%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Bright Minds Biosciences Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，180 Life Sciences Corp.、Bright Minds Biosciences Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为1299.41%、339.70%、179.32%，振幅较大的相关个股有Bright Minds Biosciences Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为161.29%、130.36%、87.25%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101823291198e3d4bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101823291198e3d4bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2475396043","title":"更新版 3-丹麦灵北公司斥资 26 亿美元收购 Longboard 公司，将赌注押在癫痫药物上","url":"https://stock-news.laohu8.com/highlight/detail?id=2475396043","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475396043?lang=zh_cn&edition=full","pubTime":"2024-10-14 18:48","pubTimestamp":1728902930,"startTime":"0","endTime":"0","summary":"更新版 3-丹麦灵北公司斥资 26 亿美元收购 Longboard 公司，将赌注押在癫痫药物上在第 8 段中增加了分析师评论，并在整个段落中增加了背景信息Puyaan Singh路透10月14日 - H Lundbeck A/S HLUNb.CO已同意以26亿美元的价格收购总部位于美国的Longboard Pharmaceuticals LBPH.O，这标志着这家丹麦制药商达成了有史以来最大的一笔交易，因为它正寻求通过一种潜在的癫痫大片药物来加强其产品组合。Longboard公司的bexicaserin正处于后期开发阶段，可用于治疗由Dravet综合征以及包括Lennox Gastaut综合征在内的其他DEE引起的癫痫发作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241014:nL4T3LQ0PS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0109394709.USD","BK4007","MRNS","BK4532","LBPH","LU0889565916.HKD","JAZZ","BK4533"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.marinuspharma.com","stockEarnings":[{"period":"1week","weight":-0.1262},{"period":"1month","weight":-0.8323},{"period":"3month","weight":-0.7605},{"period":"6month","weight":-0.7731},{"period":"1year","weight":-0.9505},{"period":"ytd","weight":-0.9722}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marinus Pharmaceuticals, Inc.于2003年8月14日在特拉华州成立。该公司是一家临床阶段生物制药公司，专注于开发创新性神经精神疗法并将其商业化。该公司的临床阶段候选产品甘纳索龙是一种小分子，它是异孕烯醇的合成类似物，异孕烯醇是一种在中枢神经系统中产生的内源性神经甾体，调节大脑神经递质γ-氨基丁酸（GABA）。该公司对加那索龙的主要适应症是作为一种辅助或附加疗法，用于治疗成人癫痫患者部分发作（也称为局灶性发作）。该公司已在147名局灶性发作癫痫患者中完成了一项2期临床试验，表明与添加安慰剂的患者相比，在用药方案中添加加那索龙的患者癫痫发作率显著降低。Marinus Pharmaceuticals目前正在招募患者参加一项随机的2b期临床试验，该公司打算扩大该试验，以便在向美国食品和药物管理局（FDA）或欧洲药品管理局（EMA）提交的关于加那索龙治疗癫痫的注册文件中，作为其充分且受控的临床试验之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.037828},{"month":2,"riseRate":0.6,"avgChangeRate":-0.012045},{"month":3,"riseRate":0.5,"avgChangeRate":0.033633},{"month":4,"riseRate":0.5,"avgChangeRate":-0.069609},{"month":5,"riseRate":0.5,"avgChangeRate":-0.007141},{"month":6,"riseRate":0.5,"avgChangeRate":0.034813},{"month":7,"riseRate":0.6,"avgChangeRate":0.022118},{"month":8,"riseRate":0.454545,"avgChangeRate":0.029644},{"month":9,"riseRate":0.636364,"avgChangeRate":0.195949},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.205727},{"month":11,"riseRate":0.363636,"avgChangeRate":0.022789},{"month":12,"riseRate":0.6,"avgChangeRate":0.123461}],"exchange":"NASDAQ","name":"Marinus Pharmaceuticals","nameEN":"Marinus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marinus Pharmaceuticals,MRNS,Marinus Pharmaceuticals股票,Marinus Pharmaceuticals股票老虎,Marinus Pharmaceuticals股票老虎国际,Marinus Pharmaceuticals行情,Marinus Pharmaceuticals股票行情,Marinus Pharmaceuticals股价,Marinus Pharmaceuticals股市,Marinus Pharmaceuticals股票价格,Marinus Pharmaceuticals股票交易,Marinus Pharmaceuticals股票购买,Marinus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}